If we talk about European 3D bioprinting, we have to understand that Poietis It is precisely one of the most important companies in all of France, an entity in this type of sector that today has specialized in working with living cells, more specifically in the reproduction of tissues with hair follicles.
A few months ago the company launched a crowdfunding campaign where they seek to increase their capital with financing of about 2 million euros. Seven days after the campaign had started, Fabien Guillemont commented how these first results have been taken in the company:
The total amount of subscriptions in these first 7 days has been 383.000 euros. We have 2 years ahead for any interested party to contribute their grain of sand and this amount has been reached in just 7 days. It's a great start that should allow us to achieve our goals. There are already more than 300 people who have invested, among these first 300 investors, a third are members of the first campaign, thank you for renewing your confidence.
Poetis, through Wired, seeks to obtain financing of around 2 million euros
Thanks to this millionaire investment, in Poetis they hope, in collaboration with Inserm, to be able to create a machine that allows them to be able to position themselves at the forefront of world 3D bioprinting, specifically a machine equipped with a laser that combines the 6 patents that today Today they are owned by the French company and that would allow us to work with the highest resolution ever achieved with cell-to-cell printing capability.
The true objective of Poetis with this new machine is to increase the amount of fabric that can be manufactured today, that is, they want to go from a few mm2 or, in the best of cases, cm2 to achieve produce enough tissue to be implanted in a human being, a milestone they hope to achieve before 2021.